Global News

The Flexion Therapeutics (FLXN) Given "Outperform" Rating at BMO Capital Markets

The Flexion Therapeutics (FLXN) Given

1492 Capital Management LLC now owns 23,892 shares of the specialty pharmaceutical company's stock worth $598,000 after buying an additional 5,039 shares during the last quarter. When the quarterly earnings report is released, investors watch closely to see if the company is performing up to expectations. Average true range (ATR-14) of the company sets at 1.43, along with its weekly and monthly volatility of 5.65% and 6.04% respectively. The stock increased 0.91% or $1.12 during the last trading session, reaching $124.21. About 595,219 shares traded. It has underperformed by 1.14% the S&P500. American Century Companies Inc stated it has 108,026 shares. The Relative Volume value measured for Flexion Therapeutics, Inc. stands at 1.45. This is 34.68 % from the last stock close.

Shares of Flexion Therapeutics Inc (FLXN) opened at $26.73 on Friday. It has outperformed by 65.32% the S&P500.The move comes after 6 months positive chart setup for the $1.03 billion company. Given that liquidity is king in short-term, ARQL is a stock with 86.17 million shares outstanding that normally trades 0.85% of its float.

Several large investors have recently added to or reduced their stakes in FLXN.

In terms of Buy/Sell recommendations, 7 analysts have a consensus rating of 1.14 on the shares of Flexion Therapeutics (NASDAQ:FLXN). Therefore 100% are positive. The firm earned "Outperform" rating on Monday, October 9 by BMO Capital Markets.

Investors also need to beware of the Flexion Therapeutics, Inc. (NASDAQ:FLXN) on Friday, September 15 with "Buy" rating. BMO Capital Markets maintained Flexion Therapeutics, Inc. As per Monday, June 12, the company rating was maintained by Cantor Fitzgerald. The company was initiated on Wednesday, November 4 by Cantor Fitzgerald. On Friday, March 9 the stock rating was maintained by BMO Capital Markets with "Outperform". (NASDAQ:FLXN) earned "Buy" rating by Needham on Wednesday, September 9. (NASDAQ:FLXN) on Monday, October 30 with "Buy" rating.

Investors sentiment decreased to 1.22 in 2017 Q3. 22 funds opened positions while 28 raised stakes. Capital Ww Invsts invested in 0.01% or 2.54M shares. Balyasny Asset Mngmt Ltd has invested 0.02% of its portfolio in Visteon Corporation (NASDAQ:VC).




The New York-based Ratan Capital Limited Partnership has invested 0.47% in Flexion Therapeutics, Inc. (NASDAQ:FLXN). Wells Fargo Mn reported 151,849 shares.

Flexion Therapeutics, Inc. (FLXN) exchanged hands at an unexpectedly high level of 1.03 million shares over the course of the day. Finally, Teacher Retirement System of Texas acquired a new stake in Flexion Therapeutics in the 4th quarter valued at approximately $245,000. Scholtz & Ltd Co holds 1.05% in Flexion Therapeutics, Inc. (NASDAQ:FLXN) is a huge mover today! Ionic Cap Mngmt Ltd Limited Liability Company owns 226,964 shares. Its beta value stands at 0.71. (NASDAQ:FLXN). Eaton Vance Management invested 0% of its portfolio in Flexion Therapeutics, Inc. (NASDAQ:FLXN). Jpmorgan Chase And invested in 164,400 shares or 0% of the stock. Wasatch Advsrs Inc holds 0.33% of its portfolio in Flexion Therapeutics, Inc. Us National Bank De invested in 0% or 131 shares. (NASDAQ:FLXN). New York State Common Retirement Fund holds 37,893 shares. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company's stock.

Analysts expect Sunworks, Inc. They set a "buy" rating and a $42.00 target price on the stock. $38.89's average target is 45.49% above currents $26.73 stock price. The stock of D.R. Horton, Inc. The company was upgraded on Monday, July 31 by Wells Fargo. (NYSE:DHI) has "Hold" rating given on Tuesday, January 9 by Keefe Bruyette & Woods. The rating was downgraded by Barclays Capital to "Equal-Weight" on Tuesday, May 3. The rating was maintained by RBC Capital Markets with "Hold" on Wednesday, August 30. (NYSE:DHI) rating on Thursday, July 13. The rating was maintained by Northland Capital on Wednesday, October 4 with "Buy". The firm has "Market Perform" rating given on Thursday, June 23 by Raymond James. The company has market cap of $22.68 million.

Long Pond Capital Lp, which manages about $1.63B and $2.77 billion US Long portfolio, decreased its stake in La Quinta Hldgs Inc (NYSE:LQ) by 357,288 shares to 1.16 million shares, valued at $20.29 million in 2017Q3, according to the filing. Jane Street Group LLC bought a new position in Flexion Therapeutics during the 4th quarter worth $352,000.

The company's quick ratio for most recent quarter is 13 along with current ratio for most recent quarter of 13. Shares for $903,031 were sold by DOUGLAS MARK on Wednesday, February 14.